These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24499089)

  • 21. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
    Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
    BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid.
    Inoue N; Yamazaki Z; Oda T; Sugiura M; Wada T
    Trans Am Soc Artif Intern Organs; 1977; 23():699-702. PubMed ID: 910402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
    Nagata Y; Kato K; Miyamoto T; Hirano H; Shoji H; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Matsushita H; Nagashima K; Saruta M; Boku N
    Support Care Cancer; 2020 Dec; 28(12):5861-5869. PubMed ID: 32253601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.
    Yoshizawa M; Nakatsuji Y
    Ther Apher Dial; 2019 Jun; 23(3):233-236. PubMed ID: 31033153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites.
    Orimi S; Mizuno K; Narahara M; Umakosi H; Kaihara M; Hashimoto M
    Ther Apher Dial; 2011 Aug; 15(4):411-4. PubMed ID: 21884478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical evaluation of processed ascites in patients undergoing cell-free and concentrated ascites reinfusion therapy.
    Nakamura H; Hanafusa N; Kitamura K; Nakamura H; Sekihara H; Shimizu K; Anayama M; Makino Y; Tamura K; Nagasawa M
    Ther Apher Dial; 2020 Oct; 24(5):516-523. PubMed ID: 32524759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan.
    Iwasa M; Ishihara T; Kato M; Isoai A; Kobayashi R; Torii N; Soneda N; Takei Y
    Intern Med; 2019 Nov; 58(21):3069-3075. PubMed ID: 31292400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites.
    Matsusaki K; Orihashi K
    Artif Organs; 2020 Oct; 44(10):1090-1097. PubMed ID: 32242939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technical Performance and Clinical Effectiveness of Drop Type With Adjustable Concentrator-Cell Free and Concentrated Ascites Reinfusion Therapy.
    Yamada Y; Harada M; Yamaguchi A; Kobayashi Y; Chino T; Minowa T; Kosuge T; Tsukada W; Hashimoto K; Kamijo Y
    Artif Organs; 2017 Dec; 41(12):1135-1144. PubMed ID: 28589706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis.
    Chen H; Ishihara M; Horita N; Tanzawa S; Kazahari H; Ochiai R; Sakamoto T; Honda T; Ichikawa Y; Watanabe K; Seki N
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives.
    ; Matsusaki K; Ohta K; Yoshizawa A; Gyoda Y
    Int J Clin Oncol; 2011 Aug; 16(4):395-400. PubMed ID: 21347629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell-Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites.
    Ohashi A; Nakai S; Yamada S; Kato M; Hasegawa M
    Ther Apher Dial; 2019 Jun; 23(3):242-247. PubMed ID: 31033167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
    Zaak D; Paquet KJ; Kuhn R
    Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer.
    Maeda O; Ando T; Ishiguro K; Watanabe O; Miyahara R; Nakamura M; Funasaka K; Kazuhiro F; Ando Y; Goto H
    Mol Clin Oncol; 2014 Nov; 2(6):1103-1106. PubMed ID: 25279205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.
    Yasuda K; Asou M; Asakawa T; Araki M
    J Med Case Rep; 2020 Oct; 14(1):192. PubMed ID: 33050943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
    Namisaki T; Tsuji Y; Kitade M; Yorioka N; Fujinaga Y; Sawada Y; Nishimura N; Kitagawa K; Inoue T; Takaya H; Kaji K; Kawaratani H; Moriya K; Akahane T; Mitoro A; Yoshiji H
    In Vivo; 2022; 36(3):1477-1484. PubMed ID: 35478114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
    Matsusaki K
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reappraisal of a Renovated Cell-free and Concentrated Ascites Reinfusion Therapy for Malignant Ascites.
    Kim Y; Ajiki T; Ueda Y; Yoshida Y; Takahashi T; Fukuyama H; Fukuyama T; Hori Y
    Anticancer Res; 2024 Feb; 44(2):613-619. PubMed ID: 38307557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluid.
    Villeneuve JP; Thuot C; Marleau D; Joly JG; Huet PM; Viallet A
    Can Med Assoc J; 1977 Dec; 117(11):1296-8. PubMed ID: 72594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
    Shimizu S; Ohira M; Nakano R; Imaoka Y; Sato K; Tahara H; Ide K; Kobayashi T; Kuroda S; Ono H; Tanaka Y; Ohdan H
    Transplant Proc; 2019 Oct; 51(8):2740-2744. PubMed ID: 31563243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.